MoneyWorks4Me

Pfizer - Quaterly Results

28 Oct 2023 Evaluate
The sales declined to Rs. 5752.10 millions for the September 2023 quarter as compared to Rs. 6374.70 millions during the corresponding quarter last year.Profit after Tax for the quarter ended September 2023 saw a decline of -52.11% from Rs. 3110.70 millions to Rs. 1489.60  millions.The Operating Profit of the company witnessed a decrease to 2186.80 millions from 2559.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 5752.10 6374.70 -9.77 11065.70 12303.70 -10.06 24247.60 26109.90 -7.13
Other Income 360.70 242.40 48.80 695.30 422.60 64.53 1010.50 626.50 61.29
PBIDT 2186.80 2559.30 -14.55 3628.50 4658.00 -22.10 9099.10 8983.80 1.28
Interest 27.30 33.80 -19.23 56.00 70.20 -20.23 133.90 104.90 27.65
PBDT 2159.50 4414.70 -51.08 3572.50 5113.70 -30.14 9295.20 8878.90 4.69
Depreciation 154.30 262.50 -41.22 309.80 527.60 -41.28 1055.10 1150.00 -8.25
PBT 2005.20 4152.20 -51.71 3262.70 4586.10 -28.86 8240.10 7728.90 6.61
TAX 515.60 1041.50 -50.49 837.80 1149.90 -27.14 2000.80 1603.30 24.79
Deferred Tax 42.20 -31.90 -232.29 30.10 -186.00 -116.18 -519.10 -359.30 44.48
PAT 1489.60 3110.70 -52.11 2424.90 3436.20 -29.43 6239.30 6125.60 1.86
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 38.02 40.15 -5.31 32.79 37.86 -13.39 37.53 34.41 9.06
Peers
Company Name CMP
Sun Pharma. Inds. 1848.95
Dr. Reddys Labs. 1210.10
Cipla 1383.85
Lupin 2117.60
Zydus Lifesciences 1170.50
View more..